Eli Lilly Acquires Breakthrough T1D T1D Fund Portfolio Company Protomer Technologies
Breakthrough T1D is excited to announce that the T1D Fund portfolio company Protomer Technologies, who is developing "smart" insulin, has been acquired by Eli…
Bigfoot Is Real—and Received FDA Clearance
The Bigfoot Unity™ Diabetes Management by Bigfoot Biomedical received FDA clearance for individuals 12 and older.
FDA Breakthrough Therapy Designation for TTP399—A Potential First-in-Class Adjunct Therapy in T1D
The FDA granted Breakthrough Therapy designation for vTv Therapeutics’ TTP399 as an adjunct therapy to insulin for T1D.
Severe Low Blood Sugar: There’s a New Treatment Option
The FDA approved Zegalogue® (dasiglucagon) injection, for the treatment of severe hypoglycemia in children and adults with diabetes aged 6…
I Still Have Diabetes, But with My CGM I’m Thriving
This educational content is made possible with support from Abbott, the makers of the FreeStyle Libre 2. Editorial control rests…
Breakthrough T1D Video: “We’ve Been Too Focused on [Insulin]”
“We’ve been too focused on [insulin],” Jeremy Pettus, M.D., an endocrinologist at UC San Diego, says. Watch the video to…
SFC Fluidics, a Breakthrough T1D Partner, Receives Breakthrough Device Designation
SFC Fluidics, a Breakthrough T1D partner, received a breakthrough device designation for its interoperable insulin delivery pod. How is it different? Find out here.
Breakthrough T1D Report: How HbA1c Came to Be
Accurate control of blood sugar for people with type 1 diabetes (T1D) was not easy in the 1970s. At the…
Tandem Diabetes Care in the Real World
Two leaders from Tandem Diabetes Care share real-world outcomes from Tandem insulin pump users, other practical insights.
Just Doing Experiments? Well, Ones that May Have Life-Saving Potential
Smart insulin; what is that? It’s the type of insulin that Chandra Bhattacharya, Ph.D., has spent her Breakthrough T1D-funded postdoctoral…
